Showing results (131-140 of 364) with videos related to
Sort By:
Pageof 37
Wellcome Open Research|October 21, 2024
Prevalence, aetiology, and service mapping of dementia in rural Uganda. <i>Part of DEPEND Uganda (Dementia Epidemiology, unmet Need and co-Developing Solutions in Uganda).</i>Josephine Prynn, Racheal Alinaitwe, Beatrice Kimono, et al.Frontiers in Medicine|July 14, 2023
Vascular risk factors for COVID-19 ARDS: endothelium, contact-kinin systemMelanie Bailey, Dermot Linden, Hong Guo-Parke, et al.Eye (London, England)|May 26, 2021
The clinical relevance of ultra-widefield angiography findings in patients with central retinal vein occlusion and macular oedema receiving anti-VEGF therapyLuke Nicholson, Clara Vazquez-Alfageme, Piyali Sen, et al.The British Journal of Ophthalmology|October 17, 2015
A prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser only in centre-involving diabetic macular oedema (OZLASE study)Ling Zhi Heng, Sobha Sivaprasad, Roxanne Crosby-Nwaobi, et al.Investigative Ophthalmology & Visual Science|May 22, 2019
Topical Treatment With Brimonidine and Somatostatin Causes Retinal Vascular Dilation in Patients With Early Diabetic Retinopathy From the EUROCONDORJakob Grauslund, Ulrik Frydkjaer-Olsen, Tunde Peto, et al.Ophthalmic Epidemiology|February 28, 2012
The prevalence of type 2 idiopathic macular telangiectasia in two African populationsFerenc B Sallo, Irene Leung, Wanjiku Mathenge, et al.Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|October 30, 2020
The effect of eye disease, cataract surgery and hearing aid use on multisensory integration in ageingRebecca J Hirst, Annalisa Setti, Céline De Looze, et al.The British Journal of Ophthalmology|May 10, 2022
Cardiovascular morbidity and all-cause mortality in patients with retinal vein occlusion: a Danish nationwide cohort studyKatrine Hartmund Frederiksen, Lonny Stokholm, Peter Hartmund Frederiksen, et al.Ophthalmology. Retina|February 26, 2026
Tomographic biomarkers differ by progression risk to late macular degenerationEnrico Bernardi, Usha Chakravarthy, Katherine A Muldrew, et al.Ophthalmology. Retina|July 2, 2026
Masquerading disease of macular telangiectasia type 2 - MacTel Project Report No 11Laurenz Pauleikhoff, Peter Charbel Issa, Tjebo F C Heeren, et al.Pageof 37